Cell 2026 Logo (Dark)_1

The event has now concluded

Thank you to everyone who joined us in London and helped make it such a success. Check back soon for updates on Cell 2027!

November 2027
London, UK

Download the Event App

Access the agenda, connect with fellow attendees and review your 1:1 meetings, all in one place

Apple App Store
Google Play Store
Phone Screen Mockup (Event App) CELL 2026 op2

Breakthroughs and Big Conversations

From lab-grown tissue for children to the future of women in science, revisit the moments that got London talking. 
01 Paolo De Coppi — Desktop 1920×560@2x (1)
02 Women in Life Sciences — Desktop 1920×560@2x
03 Investment Forum — Desktop 1920×560@2x

Two Days. Countless Moments.

Browse our curated gallery from Cell 2026 in London, and see if you can spot yourself or a familiar face. 

Cell 2027

Welcome to Cell, Oxford Global’s flagship event, serving as the ultimate meeting place for bioprocessing and advanced therapy professionals. This event brings together leaders from pharma, biotech, academia, and regulatory institutions across the entire cell culture and cell & gene therapy value chain. In line with current industry trends, the event explores the transformative power of AI and machine learning in manufacturing, driving innovation and efficiency in advanced therapies.

Don't miss the opportunity to connect with over 800+ leaders through 400+ meetings, 50+ hours of content and 13+ hours of dedicated networking solutions designed to foster collaboration and accelerate advancements.
Cell 2026 Homepage Top Image
Cell Square Image

About

Discover more about our ecosystem of channels for the biologics R&D community

Cell 2025 - Attend Icon

Attend

Be part of the new wave of Biomed R&D innovation

Partner Image

Partner

Showcase your offering to leading pharma and biotech decision makers

Cell 2026 Whats On Image

Programme

Explore dynamic panels, engaging roundtables, and hands-on workshops

Key Event Highlights

An unmissable journey awaits you: from a dedicated half-day investment forum to an interactive, expert-led pre-event workshop by Sony Biotechnology. Discover the moments that will transform your Cell experience. 

sony_logo_black

11 November 2026

Pre-Event Workshop: Translating the Next Generation of Cell Therapies from Bench to Bedside

Join Sony and leading experts for a focused pre-event workshop exploring the science, manufacturing, regulatory and investment strategies shaping the next generation of cell therapies. Gain practical insights, hear from leaders across the European ecosystem and make valuable connections before the main event begins.

NextGen Biomed 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

Proteins, Antibodies & ADCs
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?

Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow, Lundbeck; Andrew Buchanan, Principal Scientist, AstraZeneca

Peptides
Presentation: What Does The Future Hold For Orally Available Peptides?

Presented by: Immanuel Lerner, Chief Executive Officer, 
Pepticom

Oligonucleotides
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery

Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panellists include 

Saul Martinez Montero, Senior Director, RNA Therapeutics, Dyne Therapeutics
Morten Lindow, RNAHub Founder & Mission Lead, Roche
Sritama Bose, Head Of Chemistry Research & Innovation, NATA
Fazel Shabanpoor, Co-Founder & Chief Scientific Officer & Associate Professor & Head Of Pep & Oligo Therapeutics Lab, Centron Bio & The Florey Institute

 

Sustainability in Tides & Biologics
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches

Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna

Immunotherapy & Immuno-oncology
Presentation: How Vaccines & Immunotherapy Strategies: Converging Pathways For Preventing Or Treating Chronic Diseases

Presented by: Daniel Larocque, Innovation Lead, Innovation & Emerging Science, Sanofi

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful fireside chats, to an exclusive gala dinner at London's Science Museum. Discover the moments that will transform your NextGen Biomed experience. 

The Start-up Zone

The start-up zone provides a unique opportunity to for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.

It's designed for start-ups from across the cell & gene space, working on cutting-edge therapies, innovative platform technologies, products, and solutions and is an ideal platform to share your business plans.

For further information and to get started, submit the application form below.

Start-up Zone Image-1

The Investment Forum

Join an exclusive community of investors, senior decision-makers and industry leaders for high-value conversations, strategic connections and new opportunities.

The forum will combine investor-led discussion, curated company exposure, structured networking and a pitch-style feedback session, creating a targeted environment for meaningful investor–company engagement.

1to1 Photo
Cell Agenda Laptop Image alt

The Conversations That Defined 2026

See What Was on the Agenda in 2026.

Look back at the sessions, speakers and ideas that brought London’s bioprocessing and advanced therapy community together.

Featured Speakers from Cell 2026

Adam Brown
Professor of Biopharmaceutical Engineering,
University of Sheffield
Agnieszka Jozwik
Senior Research Scientist, Functional Genomics,
AstraZeneca
Ahmed Abdulgawad
Haematology Consultant, Cellular Therapy and Early Phase Trials,
NHS
Ajan Reginald
Partner, Kira Health Invest and Executive Director,
Cardiogeni PLC
Aleks Guvenel
Director - Process Development,
Quell Therapeutics
Ali Saleemi
Lead PAT Expert (Associate Director),
Bayer
Alison Caldwell
Manager, CMC Regulatory Affairs,
Resolution Therapeutics
Amelia Lane
Director of Preclinical Development,
MeiraGTx
Amy Sanders
Research Scientist,
AstraZeneca
Andreas Reimann
Principal Scientist, Cell Sciences,
Ichnos Glenmark Innovation
Anna Hoy
Associate Director, Pre-clinical Development,
Resolution Therapeutics
Anne-Sophie Thorup
Cell Culture Scientist,
Servier Symphogen
Antonio Salgado
Vice-Dean of Research,
University of Minho
Asia Majidi
Postdoctoral Scientist,
Leibniz Institute for Immunotherapy Regensburg, Germany
Balazs Sarkadi
Professor Emeritus,
Hungarian Academy of Science
Ben Weil
Chief Operating Officer, Chief Manufacturing Officer,
INmune Bio
Bernd Schmidt
Chief Technical Officer,
Sensorion
Bjorn Onfelt
Professor of Applied Physics,
KTH Royal Institute of Technology
Bo Wiinberg
Chief Business Development Officer,
Novo Nordisk Foundation Cellerator
Bozena Kaminska
Professor, Head of Laboratory,
Nencki Institute of Experimental Biology, Polish Academy of Sciences
Busola Ade-Ojo
Chief RadioPharmacist and Head of Radiopharmacy Department,
NHS
Caraugh Albany
Senior Scientist,
Autolus Ltd
Carolyn Porter
Chief Business Officer,
Cell & Gene Therapy Catapult
Chloe Hurling
Associate Senior Bioprocessing Scientist,
Cell & Gene Therapy Catapult
Clair Gallagher
Infrastructure Manager,
National Institute for Bioprocessing Research and Training
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
David Brühlmann
Global Head of Biologics Technology,
Roche
David Kentner
Senior Principal Scientist,
Novartis
David Porter
Founding Partner,
Apposite Capital
Dnyaneshwar Bhand
Principal Scientist DS Process Science,
UCB Biopharma UK
Edoardo Prediletto
Analytical Development Senior Scientist,
Autolus
Emmanuella Ekadi
Senior Bioprocess Scientist,
Cell and Gene Catapult
François Gianelli
Chief Regulatory and Quality Officer,
TreeFrog Therapeutics
Frederik De Vos
Senior Director, CAR-T Quality,
Janssen Pharmaceutical Companies of Johnson & Johnson
Gabriel Wong
Senior Medical Director, Early Respiratory and Immunology,
AstraZeneca
Giandomenico Turchiano
Team Leader,
University College London
Guiqin Wu
MSAT Indsutrialization Leader,
Sanofi
Helene Boland
Senior Associate Global Regulatory,
Hogan Lovells
Hollie Bartley
Director Process Development,
Resolution Therapeutics
Ilya Yasny
Partner,
LanceBio Ventures
Jacqueline Barry
Chief Clinical Officer,
Cell and Gene Therapy Catapult
James Fleming
Scientist,
AstraZeneca
James Tollitt
Senior Scientist, Gene Therapy,
MHRA
Janet Messer
Director of Health Data & Digital Policy,
Association of the British Pharmaceutical Industry
Jenny Prange
Head of Project Management,
Wyss Zurich
Jiawei Gu
Senior Director, Cell Therapy Product Leader,
Bristol Myers Squibb
John Bridgeman
Chief Scientific Officer,
immunokey
Jose Meseguer
Director, Digital & Data Science,
Resolution Therapeutics
Josh Bagley
Chief Scientific Officer,
a:head bio
Kerry Hallbrook
Associate Principal Scientist,
AstraZeneca
Killian Hanlon
CEO,
Lir Therapeutics
Kirsty Sharplin
Transplant Physician & Medical Director,
John Radcliffe Hospital
Konstantinos Gkatzis
Principal,
Solyco Capital UK & Europe
Laura Marie Deedigan
Head of Analytical Sciences, Cell Therapy,
Fast-Track Ventures & LIfT BioSciences
Leila Abbas
Preclinical Lead,
Rinri Therapeutics
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHSBT
Lindsay Davies
Chief Scientific Officer,
NextCell Pharma
Linn Kreins-Irle
Scientist Cell Line & Media Development,
BLUU
Manel Juan
Immunologist, Hospital Clínic de Barcelona and Research Group Leader,
IDIBAPS
Manohar Bance
Professor of Otology,
University of Cambridge
Marc Davies
Vice President, R&D,
Leucid Bio
Marcelo Rivolta
Chief Scientific Officer,
Rinri Therapeutics
Marina Tarunina
Research Director,
Plasticell
Mark Eccleston
Chief Executive Officer,
ValiRx
Mark Piskadlo
Vice President, Cell Therapy Manufacturing,
Bristol Myers Squibb
Maryam Shariatzadeh
Senior Scientist,
Rinri Therapeutics
Matthew Smart
Lead Scientist,
Cell & Gene Therapy Catapult
GenScript

The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.

 

Advanced Therapies Specialist Team Leader,
Genscript

Biosystems Acro

Biologics 2024 has been one of the best events I have attended so far in my career.

 

Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.

Bioassay

 

Impressed by the effort to bring people together.

 

Business Development Director,

Bioassay

IpA

 

Nice set-up, with good support for exhibitors

 

Director of Client Relations,

ImmunoPrecise

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Training Partner

Succession Logo - Pill_without background_final

Powering Go-To-Market For Life Science Teams

Succession helps founders and sales teams close more deals with biotech and pharma. We partner with our clients to run modern lead generation campaigns, up-skill their team through personalized sales training, and build AI workflows using cutting edge tools and technology.

Close more deals with biotech and pharma

Interested in Sponsoring Cell 2027?

Become a driving force in connecting leaders from every stage of the value chain to drive advanced therapy development & novel biologics processing. Cell 2027 offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Getting There

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.
NGB + LSX Combined Logo-1

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.

NGB Newsletter Icon-1

2025 Sponsors Include

Register Now

Be part of the new wave of bioprocessing and advanced therapy innovation,

Partner with us

Become a driving force in accelerating the next generation of cell culture and cell & gene therapy to patients